What BMI do I need for semaglutide coverage
The income is where we see most people get tripped up and miss out on subsidy: We help people with this all day long since income can be very unique to each person (think self-employed, etc)
JACC Basic Transl Sci 5:632644 Cintra RMR, Soares AAS, Breder I, Munhoz DB, Barreto J, Kimura-Medorima ST, Cavalcante P, Zanchetta R, Breder JC, Moreira C, Virginio VW, Bonilha I, Lima-Junior JC, Coelho-Filho OR, Wolf VLW, Guerra-Junior G, Oliveira DC, Haeitmann R, Fernandes VHR, Nadruz W, Chaves FRP, Arieta CEL, Quinaglia T, Sposito AC (2019) ADDENDA-BHS2 trial investigators
This meta-analysis suggests that GLP-1 RA reduce kidney disease progression in T2D or overweight/obesity regardless of CKD status bit.ly/CJASN0584 Recent data indicate a potential benefit of glucagon-like peptide-1 receptor agonists on the progression of kidney disease among patients with CKD
That has limited sustained use, especially because these medicines are typically taken over months and often longer
